Pharmaceutical applications and requirements of resins for printing by digital light processing (DLP)

Abstract

The digital light processing (DLP) printer has proven to be effective in biomedical and pharmaceutical applications, as its printing method does not induce shear and a strong temperature on the resin. In addition, the DLP printer has good resolution and print quality, which makes it possible to print complex structures with a customized shape, being used for various purposes ranging from jewelry application to biomedical and pharmaceutical areas. The big disadvantage of DLP is the lack of a biocompatible and non-toxic resin on the market. To overcome this limitation, an ideal resin for biomedical and pharmaceutical use is needed. The resin must have appropriate properties, so that the desired format is printed when with a determined wavelength is applied. Thus, the aim of this work is to bring the basic characteristics of the resins used by this printing method and the minimum requirements to start printing by DLP for pharmaceutical and biomedical applications. The DLP method has proven to be effective in obtaining pharmaceutical devices such as drug delivery systems. Furthermore, this technology allows the printing of devices of ideal size, shape and dosage, providing the patient with personalized treatment.

Keywords:

• Development
• additive manufacturing
• 3D printing
• technology
• resin
• digital light processing

Disclosure statement

The authors declare no conflict of interests.

Additional information

Funding

The authors thankful to the Brazilian agencies CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior/Coordination for the Improvement of Higher Education Personnel; Finance Code 001) and CNPq (Conselho Nacional de Desenvolvimento Científco e Tecnológico/National Council of Scientifc and Technological Development; Process n° 307695/2020-4 and 404163/2021-1).